Nerve regeneration technology
Researchers with the Center for Paralysis Research in Purdue University's School of Veterinary Medicine have developed a treatment for central nervous system injury and disease that has shown early promise in bringing quality-of-life improvements to patients with paralysis. The technology includes a platform of treatment alternatives, including a medical device called the Oscillating Field Stimulator, a combination medical device and drug, and a series of drugs, all targeting injury and diseases of the central nervous system.
The technology is licensed exclusively to Andara Life Science Inc., an Indianapolis-based company that is a subsidiary of Cyberkinetics Neurotechnology Inc.
Featured Image:
